ATE292471T1 - Peptide des tsp-i-rezeptors cd36 zur behandlung von krankheiten welche durch eine fehlregulation von tgf-beta1 verursacht werden - Google Patents

Peptide des tsp-i-rezeptors cd36 zur behandlung von krankheiten welche durch eine fehlregulation von tgf-beta1 verursacht werden

Info

Publication number
ATE292471T1
ATE292471T1 AT96914810T AT96914810T ATE292471T1 AT E292471 T1 ATE292471 T1 AT E292471T1 AT 96914810 T AT96914810 T AT 96914810T AT 96914810 T AT96914810 T AT 96914810T AT E292471 T1 ATE292471 T1 AT E292471T1
Authority
AT
Austria
Prior art keywords
tgf
beta
tsp
peptides
receptor
Prior art date
Application number
AT96914810T
Other languages
English (en)
Inventor
Nasreen Khalil
Original Assignee
Manitoba Cancer Treat And Res
Univ Manitoba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Manitoba Cancer Treat And Res, Univ Manitoba filed Critical Manitoba Cancer Treat And Res
Application granted granted Critical
Publication of ATE292471T1 publication Critical patent/ATE292471T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Silicon Polymers (AREA)
  • Steroid Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Radiation-Therapy Devices (AREA)
AT96914810T 1995-05-17 1996-05-17 Peptide des tsp-i-rezeptors cd36 zur behandlung von krankheiten welche durch eine fehlregulation von tgf-beta1 verursacht werden ATE292471T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9509957.8A GB9509957D0 (en) 1995-05-17 1995-05-17 Post-translational activation of tgf-›1 involving the tsp-1 receptor cd36
PCT/CA1996/000311 WO1996036349A1 (en) 1995-05-17 1996-05-17 POST-TRANSLATIONAL ACTIVATION OF TGF-β1 INVOLVING THE TSP-1 RECEPTOR CD36

Publications (1)

Publication Number Publication Date
ATE292471T1 true ATE292471T1 (de) 2005-04-15

Family

ID=10774593

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96914810T ATE292471T1 (de) 1995-05-17 1996-05-17 Peptide des tsp-i-rezeptors cd36 zur behandlung von krankheiten welche durch eine fehlregulation von tgf-beta1 verursacht werden

Country Status (8)

Country Link
US (1) US6090367A (de)
EP (1) EP0827407B1 (de)
AT (1) ATE292471T1 (de)
AU (1) AU5681996A (de)
CA (1) CA2221232A1 (de)
DE (1) DE69634564T2 (de)
GB (1) GB9509957D0 (de)
WO (1) WO1996036349A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004513066A (ja) * 1999-06-21 2004-04-30 インカイン ファーマシューティカル カンパニー,インコーポレイティド アンジオシジン:cys−ser−val−thr−cys−gly特異的腫瘍細胞付着受容体
JP2004121218A (ja) * 2002-08-06 2004-04-22 Jenokkusu Soyaku Kenkyusho:Kk 気管支喘息または慢性閉塞性肺疾患の検査方法
US20060019880A1 (en) * 2004-07-08 2006-01-26 Barres Ben A Modulation of synaptogenesis
WO2009043525A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Use of the combination of gluten exorphin c and cd36 as a therapeutic agent
KR20150122786A (ko) 2013-03-15 2015-11-02 펀다시오 인스티튜트 드 르세르카 바이오메디카 (아이알비 바르셀로나) 암 전이의 진단, 예후 및 치료를 위한 방법
US20160297875A1 (en) * 2013-12-07 2016-10-13 Case Western Reserve University Compositions and methods of treating thrombosis
EP3229909B1 (de) 2014-12-11 2020-10-14 Inbiomotion S.L. Bindeelemente für menschliches c-maf
CN109384830B (zh) * 2017-08-09 2021-12-03 成都惠泰生物医药有限公司 多肽、多肽片段及其衍生物在防治纤维化疾病中的应用
CA3054839C (en) 2017-03-01 2023-08-29 Chengdu Huitai Biomedicine Co., Ltd. Polypeptides and uses thereof for treatment of a fibrosis disease
CN111033258B (zh) * 2017-06-30 2023-09-05 可隆生命科学株式会社 用于评价细胞治疗产品的有效性的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
WO1992017499A1 (en) * 1991-04-08 1992-10-15 Cornell Research Foundation, Inc. A unique hexapeptide derived from thrombospondin and its uses
US5770563A (en) * 1991-12-06 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Heparin- and sulfatide binding peptides from the type I repeats of human thrombospondin and conjugates thereof
WO1993022340A1 (en) * 1992-04-30 1993-11-11 Schering Corporation Modulation of thrombospondin-cd36 interactions
US5367059A (en) * 1992-05-14 1994-11-22 W. R. Grace & Co.-Conn. Cys-Ser-Val-Thr-Cys-Gly specific tumor cell adhesion receptor

Also Published As

Publication number Publication date
EP0827407B1 (de) 2005-04-06
US6090367A (en) 2000-07-18
GB9509957D0 (en) 1995-07-12
DE69634564D1 (de) 2005-05-12
AU5681996A (en) 1996-11-29
CA2221232A1 (en) 1996-11-21
EP0827407A1 (de) 1998-03-11
WO1996036349A1 (en) 1996-11-21
DE69634564T2 (de) 2006-02-16

Similar Documents

Publication Publication Date Title
Hunter et al. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins
JP3054150B2 (ja) トロンビンから誘導されたポリペプチド、組成物およびその使用方法
CA2655116C (en) Peptide fragments for inducing synthesis of extracellular matrix proteins
Butler et al. Extracellular matrix proteins and the dynamics of dentin formation
KR930703004A (ko) 맥관형성 펩티드
US20090163413A1 (en) Dental products comprising bone growth enhancing peptide
US7202066B2 (en) Combination of a growth factor and a protease enzyme
CA2690734A1 (en) Polypeptides and methods of use
ATE292471T1 (de) Peptide des tsp-i-rezeptors cd36 zur behandlung von krankheiten welche durch eine fehlregulation von tgf-beta1 verursacht werden
AU4422797A (en) Methods and compositions for generating angiostatin
JPH08503198A (ja) Op−3誘導形態形成
Correa et al. Synthetic cementum protein 1–derived peptide regulates mineralization in vitro and promotes bone regeneration in vivo
JPH09505555A (ja) TGF−βの活性を刺激および阻害する方法および組成物
Liu et al. An N-terminal peptide from link protein can stimulate biosynthesis of collagen by human articular cartilage
Gorski et al. Developmental changes in the extracellular matrix of the dental follicle during tooth eruption
DE69128416T2 (de) Fibronektin bindendes Peptid
JPH08501779A (ja) モルフォゲン誘導歯周組織再生
JP2002512018A (ja) マトリックス結合因子
Goldberg et al. Identification of small collagenous proteins with properties of procollagen α1 (I) pN-propeptide in fetal porcine calvarial bone
Tubayesha et al. Dentin Phosphophoryn and its Possibilities in Regenerative Dentistry: A Review
KR20230122899A (ko) 항균, 항염증 또는 조직재생능을 구비하는 펩타이드 및 이의 용도
Rao et al. An autologous indigenous armour--Platelet Rich Plasma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties